Andarix Pharmaceuticals CEO to Chair Rare Disease Clinical Trials Conference
(YorkPedia Editorial):- Cambridge, Massachusetts Sep 17, 2023 (Issuewire.com) – Andarix Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for rare cancers announced today that its CEO, Chris Adams will Chair the two days conference on rare diseases. The conference will include attendees from industry experts to patient groups. The Clinical Trials in Rare Diseases Conference. This event will explore the challenges in clinical trials for orphan drugs and rare diseases, bringing together clinical operations professionals from across multiple therapeutic areas to discuss common obstacles and solutions. Topics at…
Read More